Rapeeporn Tiamjan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Rapeeporn Tiamjan has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Adriana Viola Miranda
Global Health Focus Asia Bandung Indonesia
2 shared publications - Manatee Jitanan
Department of Physical Education Faculty of Education Kasetsart University Bangkok Thailand
2 shared publications - Dawa Gyeltshen
Eusa Hospital, Ministry of Health, Wangdue Phodrang, Bhutan
1 shared publication Kwanjai Amnatsatsue
Faculty of Public Health Mahidol University Bangkok Thailand
1 shared publication- Manas Ranjan Behera
School of Public Health, Kalinga Institute of Industrial Technology (KIIT) Deemed to be University, Bhubaneswar, Odisha, India
1 shared publication - Mattheus Bartholomeus Nicolaas Kouwenhoven
Department of Physics, Xi’an Jiaotong-Liverpool University, Suzhou, China
1 shared publication
Latest Publications
- Open Access
- 1 February 2023
- Published by Wiley in Public Health Challenges
- Vol. 2 (1)
COVID‐19 vaccine wastage in Thailand amidst vaccine inequity and pandemic‐to‐endemic transition
COVID‐19 vaccine wastage is an emerging issue globally. In Thailand, which has declared COVID‐19 to be an endemic disease, the risk of vaccine wastage lingers despite the remaining vaccine inequity. Although the country does not publicly report its vaccine wastage rate, a wastage incident has been reported. With the remaining secured vaccine doses that have yet to be delivered and Thailand's pandemic‐to‐endemic transition, Thailand should strategize to avoid vaccine wastage. This commentary highlights several factors that can potentially lead to vaccine wastage in Thailand: cold chain logistics issues, vaccine hesitancy, and unequal vaccine accessibility. The Thai government should continue its efforts in mitigating these issues to maximize its vaccination program.
- 1 February 2023
- Published by Wiley in Public Health Challenges
- Vol. 2 (1)
Open AccessCOVID‐19 vaccine wastage in Thailand amidst vaccine inequity and pandemic‐to‐endemic transition
COVID‐19 vaccine wastage is an emerging issue globally. In Thailand, which has declared COVID‐19 to be an endemic disease, the risk of vaccine wastage lingers despite the remaining vaccine inequity. Although the country does not publicly report its vaccine wastage rate, a wastage incident has been reported. With the remaining secured vaccine doses that have yet to be delivered and Thailand's pandemic‐to‐endemic transition, Thailand should strategize to avoid vaccine wastage. This commentary highlights several factors that can potentially lead to vaccine wastage in Thailand: cold chain logistics issues, vaccine hesitancy, and unequal vaccine accessibility. The Thai government should continue its efforts in mitigating these issues to maximize its vaccination program.
- Open Access
- 7 June 2022
- Published by Wiley in Public Health Challenges
- Vol. 1 (2)
Can Thailand achieve COVID‐19 herd immunity?
The COVID‐19 outbreak has had a great impact on the social, economic, and health systems of Thailand. A variety of measures to curb the spread of the disease were implemented since the beginning of the pandemic, including a strict national lockdown protocol. The Thai government aimed to achieve herd immunity through an efficient vaccination programme. Initially, vaccine supply shortage and a lack of vaccine options plagued the health system, but this has since been improved. Continuous monitoring of the situation through research is being carried out to assess the level of immunity among the population whereby the current general recommendation is presently a fourth booster dose for adults. Hurdles towards achieving herd immunity remain. One such issue is the low level of vaccine literacy among those that are unvaccinated or inadequately vaccinated. Another obstacle is the sizeable rate of hesitancy towards getting booster doses. Achieving herd immunity in the Thai population would require multilateral cooperation, improved health promotion to target population groups, such as older adults, and a developed distribution system for those with limited access, such as those in the rural areas.
- 7 June 2022
- Published by Wiley in Public Health Challenges
- Vol. 1 (2)
Open AccessCan Thailand achieve COVID‐19 herd immunity?
The COVID‐19 outbreak has had a great impact on the social, economic, and health systems of Thailand. A variety of measures to curb the spread of the disease were implemented since the beginning of the pandemic, including a strict national lockdown protocol. The Thai government aimed to achieve herd immunity through an efficient vaccination programme. Initially, vaccine supply shortage and a lack of vaccine options plagued the health system, but this has since been improved. Continuous monitoring of the situation through research is being carried out to assess the level of immunity among the population whereby the current general recommendation is presently a fourth booster dose for adults. Hurdles towards achieving herd immunity remain. One such issue is the low level of vaccine literacy among those that are unvaccinated or inadequately vaccinated. Another obstacle is the sizeable rate of hesitancy towards getting booster doses. Achieving herd immunity in the Thai population would require multilateral cooperation, improved health promotion to target population groups, such as older adults, and a developed distribution system for those with limited access, such as those in the rural areas.